Case File
efta-efta00871462DOJ Data Set 9OtherFrom: Ellen Harrison
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00871462
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Ellen Harrison
To: Jeffrey Epstein <[email protected]>
Cc: Mortimer Zuckerman
Subject: Re: M
Date: Mon, 13 Jan 2014 13:25:08 +0000
>
On your question about Mort's basis in the notes, I checked with Brian and He said the notes had not been
written down so I gave you bad information. Sony.
In my opinion, your purchase of the receivables from Mort would not cure the COD issue we are worried about.
Even if the sale generated a capital loss, that would not offset ordinary income from COD. However, we will
continue to explore this along with other ideas
My partner is working on an accounting for the 1983 and 1996 trusts. She is still getting data. This has been in
process for less than a month. I expect that it will be some time before it is done because I am told that the
records prior to 2000 are limited.
SRR is appraising R&R. We are hoping, of course, that the cash flow will be sufficient to cover the preference.
Since we don't have the appraisal or the preference yet we don't know whether this will be a problem. If it is, I
would use debt to reduce value so cash flow would cover the preference. This is a problem under section 2701,
because the common has to equal 10% of enterprise value before debt, but we will figure it out.
Sent from my iPhone
On Jan 13, 2014, at 7:19 AM, Jeffrey Epstein <[email protected]> wrote:
EH you told me that morts basis in the 12 percent notes had been written down, can you explain, . can you
tell me the status of the trust accounting to date. ? you stated that Rand R was being valued, and planned to
put it in a preferred partnership. ? what is the plan if the cashflow is not enough to pay the preferred. ?
On Sun, Jan 12, 2014 at 2:30 PM, Ellen Harrison <
> wrote:
> Hello
> I just left you a voicemail. I would like to speak with you briefly about the terms of the deal you proposed
to MZ so that we can give it appropriate analysis. Could you please give me a call at
or reply
to this email as soon as possible? We are trying to schedule a conference call with tax advisors on Monday
between 10 and 12 and it would be very helpful to have your proposal in hand by then.
> Thanks and Happy New Year.
> Sent from my iPhone
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
EFTA00871462
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00871463
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.